compounded semaglutide fsa eligible Coverage for FSA Eligibility for Compounded Semaglutide
Description
Retatrutide remains under clinical investigation and has not yet received regulatory approval, with ongoing Phase 3 trials evaluating long-term safety and effectiveness
It does not persist permanently
Ask your provider about prior authorization requirements
A Master Protocol to Investigate the Efficacy and Safety of LY3437943 Once Weekly in Participants Without Type 2 Diabetes Who Have Obesity or Overweight (TRIUMPH-1)
In practical terms, the obesity threshold drops from BMI 30 to 27.5, and the overweight-with-comorbidity threshold drops from 27 to 24.5
